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Molecular Epidemiologic Analysis of Methicillin-Resistant 
Staphylococcus aureus Isolates from Bacteremia and Nasal 
Colonization at 10 Intensive Care Units: Multicenter Prospective 
Study in Korea
We investigated molecular epidemiology of methicillin-resistant Staphylococcus aureus 
(MRSA) isolated at 10 intensive care units (ICUs) in Korea. MRSA isolates from bacteremia 
and nasal colonization were collected prospectively from October 2008 through May 2009 
at 10 University-affiliated hospital ICUs. A total of 83 and 175 MRSA strains were isolated 
from bacteremia and nasal colonization, respectively. Acquired group accounted for 
69.9% (n = 58) of bacteremia and 73.1% (n = 128) of nasal colonization. Pulsed-field gel 
electrophoresis (PFGE) type B (SCCmec type II/ST5) was dominant in the acquired group 
followed by PFGE type D (SCCmec type IVA/ST72; a community genotype). Seven of 
58 (12.1%) acquired bacteremia and 15 of 128 (11.8%) acquired nasal colonizations had 
SCCmec type IVA/ST72 genotype, which indicated that the community genotype had 
already emerged as a cause of ICU acquired MRSA infection or colonization. Antibiotic 
resistance rates to ciprofloxacin, tetracycline, clindamycin and trimethoprim/
sulfamethoxazole were 84.4%, 67.1%, 78.1%, and 12.0%, respectively. Susceptibility to 
ciprofloxacin best predicted a community genotype (sensitivity 96.5%; specificity 96.9%; 
odds ratio 861; 95% confidence interval 169-4,390, P < 0.001) and the positive predictive 
value was 90.2%. Among 23 nasal re-colonized strains, 7 MRSA strains (30.4%) were 
different from the originally colonized strains on the basis of PFGE types.
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INTRODUCTION
Staphylococcus aureus is a major cause of serious infections in 
both hospitals and the community and the increasing rates of 
MRSA infection is now a health problem worldwide (1). The fre-
quency of MRSA from tertiary hospitals in Korea was reported 
to account for 60%-70% of all S. aureus isolates (2) and MRSA is 
more prevalent in ICU setting than non-ICU setting among in-
patients (3). Bacteremia was three times more common in S. 
aureus nasal carriers than non-carriers (4), and MRSA nasal car-
riage increased MRSA infections at ICUs (5, 6). From this point 
of view, understanding the molecular epidemiology of MRSA 
from bacteremia and nasal carriage may be useful for under-
standing the source and transmission of MRSA in ICU settings.
  The most commonly used typing techniques for S. aureus are 
pulsed field gel electrophoresis (PFGE), multilocus sequence 
typing (MLST), Staphylococcus protein A (spa) typing, and staph-
ylococcal cassette chromosome mec (SCCmec) typing. PFGE is 
considered the best method to investigate MRSA outbreaks in 
hospitals, as well as hospital-to hospital transmission of MRSA 
but is a time-consuming process (7). Therefore, genotyping is 
not a routine test in daily clinical practice. Recently, there was a 
report that specific genotype could be predicted by antibiotic 
susceptibility in bloodstream MRSA infections (8). Whether this 
phenotypic rule could be applied to MRSA isolates other than 
bacteremia or from other geographic regions in a similar man-
ner is left to question.
  The aims of this study were to analyze the molecular epide-
miology of MRSA isolates from bacteremia and nasal coloniza-
tion and to find out the relationship between phenotype and 
genotype of MRSA isolates from ICUs in Korea.
 
MATERIALS AND METHODS
Study design and data collection
This study was a prospective multicenter surveillance of bacte-
remia and nasal carriage of MRSA at 10 university-affiliated 
hospital ICUs in Korea from October 2008 through May 2009. Kwon J-C, et al.  •  Molecular Epidemiology of MRSA Isolates at Intensive Care Units
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The participating institutions included Bucheon St. Mary’s Hos-
pital, Kyunghee University Medical Center, Soonchunhyang 
University Bucheon Hospital, Daejeon St. Mary’s Hospital, Hal-
lym University Kangnam Sacred Heart Hospital, Hanyang Uni-
versity Seoul Hospital, Ilsan Hospital, Korea University Guro 
Hospital, Incheon St. Mary’s Hospital and Yeouido St. Mary’s 
Hospital. Cases of MRSA bacteremia were collected from all 
participating hospitals, but cases of nasal carriage of MRSA only 
from the first 3 hospitals.
  All patients were older than 15 yr. In case of nasal carriers, pa-
tients without MRSA infection and expected to stay more than 
48 hr at ICU were included and patients already infected with 
MRSA or planned to be discharged from ICU within 48 hr were 
excluded.
  The following data were collected from all cases; demograph-
ic information, underlying diseases, comorbid conditions, pre-
vious medical and surgical history, microbiological data, sourc-
es of infections, presence of indwelling catheters, and other im-
portant clinical parameters at the time of infection. Health care-
associated risk factors included history of MRSA infection or 
colonization, use of antibiotics or steroid, dialysis, the presence 
of an invasive device (e.g. vascular catheter, urinary catheter, gas-
tric feeding tube, or tracheostomy tube), and a history of hospi-
talization, surgery, long-term care facility within one year prior 
to the MRSA culture date.
Definitions
MRSA bacteremia was defined as isolation of MRSA from at least 
2 separate blood cultures within 24 hr or 1 blood culture with 
clinical significance. Only the first isolate was included when 
multiple positive cultures were obtained from one patient.
  Nasal carriage was defined as the presence of MRSA in a nasal 
swab culture. Eradication was defined as the clearance of MRSA 
in the following 3 consecutive nasal swab cultures after decolo-
nization. Recolonization was defined as the first presence of 
MRSA in a nasal swab culture following successful eradication.
  Each case of MRSA bacteremia or nasal colonization was clas-
sified as either ‘imported’ or ‘acquired’ depending on the hours 
from the date of ICU admission to the date of culture-positive 
specimens. Imported bacteremia or colonization was defined 
as a positive culture sample obtained within 72 hr after ICU ad-
mission and acquired bacteremia or colonization was defined 
as a positive culture sample obtained on or later than 72 hr after 
ICU admission (9).
  Community genotype (CG) was defined as SCCmec type IVA/ 
ST72 strain based on epidemiologic data in Korea (10-12).
Active surveillance, decolonization and infection control 
measures
For all study patients, nasal swabs were taken for surveillance 
cultures of MRSA. Surveillance cultures were performed weekly 
starting the admission date until ICU discharge. Nasal swab spec-
imens were transported in Amie’s medium (Micromedia Co., 
Seoul, Korea) and were streaked directly on sheep blood agar 
plate (D-BAP) (Asan Medical Co., Seoul, Korea), incubated at 
35°C, and examined at 24 and 48 hr. Suspicious colonies were 
identified as S. aureus by catalase production, positive clumping 
test, or positive tube coagulase test. MRSA was confirmed by 
cefoxitin disk diffusion susceptibility testing according to clinical 
and laboratory standards institute (CLSI) guidelines (13). All iso-
lates identified from each hospital were transported to the Cath-
olic Research Institutes of Medical Science for molecular typing.
  In case of MRSA nasal carriers, decolonization was preform-
ed with mupirocin intranasally once daily for 5 days and daily 
chlorhexidine gluconate bathing for 3 days. Patients with MRSA 
colonization or infection were placed in contact isolation in sin-
gle rooms or if a single room was not available, cohorting was 
acceptable. A clinical warning was entered into the electronic 
medical record and the patient’s bedside identifying the patient 
as positive for MRSA. The use of gloves and masks was required 
for all contacts with a patient in contact isolation. Putting on gog-
gles was recommended, if necessary. The patient’s care was pro-
vided by the smallest possible regular team with doctors and 
nurses. Contact with other healthcare workers and visitors was 
kept to a minimum. Hand-hygiene was emphasized again be-
fore and after contact with these patients.
 
Identification of microorganism
Identification of MRSA and antimicrobial susceptibility tests 
were performed on the Vitek II automated system with GP cards 
and AST-P601 cards (bioMérieux, Hazelwood, MO, USA), re-
spectively, or MicroScan Pos Combo Panel Type 6 automated 
system with combination PBC28 cards (Baxter Diagnostics, West 
Sacramento, CA, USA).
Molecular typing studies
Molecular typing of all MRSA isolates was performed using 
PFGE, MLST, and spa typing method as described elsewhere 
(14-18). The spa complex was defined by visual analysis, in which 
spa types with similar short sequence repeats were clustered 
into complexes, as described by Ruppitsch et al. (16) and Park 
et al. (10). The SCCmec types were determined by multiplex 
PCR, as described by Oliveira et al. (19). Nontypeable strains 
were defined as strains that showed unexpected fragments or 
that lacked some fragments in multiplex PCR and thus did not 
correspond to previously defined SCCmec types.
Statistical analysis
Data analysis was performed using SPSS software, version 12.0K. 
Statistical significance was assessed via the chi-squared test or 
the Fisher exact test for categorical variables and the Student t-
test or the Mann-Whitney U-test for continuous variables. P Kwon J-C, et al.  •  Molecular Epidemiology of MRSA Isolates at Intensive Care Units
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values of less than 0.05 were considered to be statistically sig-
nificant.
Ethics statement
The study protocol was approved by the institutional review 
board at Bucheon St. Mary’s Hospital and each participating 
hospital as a continuous quality improvement project with a 
waiver of informed consent (Approval number at Bucheon St. 
Mary’s Hospital: HCMC08OT007).
 
RESULTS
A total of 281 MRSA strains were isolated from 258 patients. Cas-
es of bacteremia, nasal colonization and nasal re-colonization 
consisted of 83, 175 and 23 strains, respectively.
Clinical characteristics of MRSA isolates
In bacteremia group, acquired infection accounted for 69.9% (n  
= 58). Age, sex, underlying diseases and sources of bacteremia 
were not different between the acquired and imported groups. 
Previous hospitalization and stay in long-term care facility were 
more frequent in the imported group, but only the latter showed 
significant difference. History of MRSA infections, recent anti-
biotic use, and presence of central venous catheter or indwell-
ing urinary catheter were significantly higher in the acquired 
group (Table 1). In nasal carriage group, acquired group account-
ed for 73.1% (n = 128). Underlying malignancies were more fre-
quent in the imported group. Previous antimicrobial use and 
presence of indwelling urinary catheter were significantly high-
er in the acquired group (Table 2). Among 258 cases with bacte-
remia or nasal colonization, all acquired cases had at least one 
healthcare-associated risk factors and in the imported cases, 2 
cases of bacteremia and 6 cases of nasal colonization did not 
have any healthcare-associated risk factors.
Molecular epidemiologic analysis of MRSA
Results from molecular typing of MRSA isolates by PFGE, MLST, 
spa typing and SCCmec typing are summarized in Table 3. One-
hundred sixty three MRSA isolates of PFGE type A, B, C, G, K, M, 
and O shared the same MLST profile (ST5) and spa complex A 
Table 1. Baseline dermographic and clinical characteristics of bacteremic patients
Characteristics
No. (%) of isolates
OR (95% CI) P value
Acquired (n = 58) Imported (n = 25)
Mean age ± SD (range) (yr) 61.8 ± 17.6 (17-98) 61.6 ± 16.6 (25-85) - 0.961
Male gender (%) 37 (63.8) 12 (48.0) 1.91 (0.74-4.94) 0.179
Underlying diseases (%)
   No underlying dieseases
   Cerebrovascular diseases
   Other neurologic diseases
   Malignancies
   Hepatobiliary diseases
   Renal diseases
   Cardiovascular diseases
   Respiratory diseases
   Diabetes
   Connective tissue diseases
   Others
6 (10.3)
7 (12.1)
1 (1.2)
15 (25.9)
4 (6.9)
8 (13.8)
6 (10.3)
4 (6.9)
4 (6.9)
0 (0)
3 (5.2)
1 (4.0)
4 (16.0)
0 (0)
5 (20.0)
2 (8.0)
8 (32.0)
1 (4.0)
0 (0)
3 (12.0)
1 (4.0)
0 (0)
2.77 (0.32-24.29)
0.72 (0.19-2.72)
1.44 (1.25-1.66)
1.21 (0.42-3.48)
0.96 (0.18-5.28)
0.34 (0.11-1.05)
2.77 (0.32-24.29)
1.46 (1.26-1.70)
0.54 (0.11-2.63)
3.42 (2.44-4.78)
1.46 (1.26-1.69)
0.669
0.727
1.000
0.721
1.000
0.054
0.669
0.310
0.425
0.301
0.550
Previous history of
   MRSA (%)
   Antimicrobials (%)
   Steroid (%)
   Long-term care facility (%)
   Hospitalization (%)
   Operation (%)
21 (36.2)
50 (86.2)
16 (27.6)
5 (8.6)
34 (58.6)
28 (48.3)
1 (4.0)
8 (32.0)
5 (20.0)
8 (32.0)
19 (76.0)
8 (32.0)
13.62 (1.72-108.04)
13.28 (4.32-40.86)
1.52 (0.49-4.75)
0.20 (0.06-0.70)
0.45 (0.16-1.29)
1.98 (0.74-5.31)
0.002
< 0.001
0.466
0.007
0.131
0.170
Source of bacteremia (%)
   Primary
   Respiratory tract
   Endocarditis
   Central catheter
   SSTI
   Others
24 (41.4)
5 (8.6)
1 (1.7)
23 (39.7)
3 (5.2)
2 (3.4)
12 (48.0)
1 (4.0)
0 (0)
6 (24.0)
4 (16.0)
2 (8.0)
0.77 (0.30-1.96)
2.26 (0.25-20.45)
1.44 (1.25-1.66)
2.08 (0.72-5.99)
0.29 (0.06-1.39)
0.41 (0.06-3.09)
0.634
0.663
1.000
0.170
0.190
0.580
Central venous catheter (%) 46 (79.3) 7 (28.0) 9.86 (3.35-29.02) < 0.001
Urinary catheter (%) 45 (77.6) 3 (12.0) 25.39 (6.55-98.41) < 0.001
Dialysis (%) 15 (25.9) 9 (36.0) 0.62 (0.23-1.70) 0.350
Drinking (%) 11 (19.0) 6 (24.0) 0.74 (0.24-2.29) 0.602
Smoking (%) 9 (15.7) 4 (16.0) 0.96 (0.27-3.48) 0.956
OR, odds ratio; CI, confidence interval; MRSA, methicillin resistant Staphylococcus aureus; SD, standard deviation; SSTI, skin and soft tissue infections.Kwon J-C, et al.  •  Molecular Epidemiology of MRSA Isolates at Intensive Care Units
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and carried SCCmec II or II variant. All 58 isolates of PFGE type 
D shared ST72 and spa complex B and carried SCCmec type IVA. 
Of 258 isolates, 223 (88.8%) clustered into 4 major PFGE types 
(designated A, B, D, and E). The number of PFGE types was 11 
in bacteremia and 13 in nasal colonization. Among 258 isolates, 
excluding nasal re-colonization, the most frequent PFGE type 
was type B (n = 120, 46.5%), and the second was type D (n = 58, 
22.5%). There was no difference in the distribution of PFGE type 
B and D between bacteremia and nasal colonization. PFGE pat-
terns were similar except for type A. PFGE type A was detected 
in 11.4% of nasal colonization, which is significantly higher than 
1.2% of bacteremia (Table 4). Acquired group consisted of 13 
PFGE types, and type B accounted for 55.9% followed by type D 
and E, each of which comprised 11.8%. On the other hand, im-
ported group consisted of 11 PFGE types, and type D accounted 
for 50.0% followed by type B (22.2%). PFGE type B and E were 
significantly higher in the acquired group and type D in the im-
ported group (Table 4).
Table 2. Baseline dermographic and clinical characteristics of nasal carriers
Characteristics
No. (%) of isolates
OR (95% CI) P value
Acquired (n = 128) Imported (n = 47)
Mean age ± SD (range) (yr) 63.0 ± 16.6 (34-89) 63.2 ± 13.6 (18-89) - 0.952
Male gender (%) 65 (50.8) 26 (55.3) 0.83 (0.43-1.63) 0.594
Underlying diseases (%)
   No underlying dieseases
   Cerebrovascular diseases
   Other neurologic diseases
   Malignancies
   Hepatobiliary diseases
   Renal diseases
   Cardiovascular diseases
   Respiratory diseases
   Diabetes
   Connective tissue diseases
   Others
17 (13.3)
45 (35.2)
6 (4.7)
16 (12.5)
3 (2.3)
7 (5.5)
20 (15.6)
9 (7.0)
3 (2.3)
0 (0)
2 (1.6)
2 (4.3)
11 (23.4)
3 (6.4)
14 (29.8)
4 (8.5)
2 (4.3)
6 (12.8)
0 (0)
3 (6.4)
1 (2.1)
1 (2.1)
3.45 (0.77-15.53)
1.77 (0.82-3.82)
0.72 (0.17-3.01)
0.34 (0.15-0.76)
0.26 (0.06-1.20)
0.34 (0.11-1.05)
2.77 (0.32-24.29)
1.40 (1.27-1.54)
0.35 (0.07-1.81)
3.78 (2.95-4.85)
0.73 (0.07-8.25)
0.105
0.140
0.703
0.007
0.085
0.054
0.669
0.115
0.345
0.269
1.000
Previous history of
   MRSA (%)
   Antimicrobials (%)
   Steroid (%)
   Long-term care facility (%)
   Hospitalization (%)
   Operation (%)
28 (21.9)
116 (90.6)
31 (24.2)
8 (6.3)
60 (46.9)
37 (28.9)
5 (10.6)
32 (68.1)
12 (25.5)
7 (14.9)
22 (46.8)
10 (21.3)
2.35 (0.85-6.51)
4.53 (1.93-10.64)
0.93 (0.43-2.01)
0.38 (0.13-1.12)
1.00 (0.51-1.96)
1.50 (0.68-3.34)
0.092
< 0.001
0.858
0.070
0.994
0.313
Central venous catheter (%) 64 (50.0) 16 (34.0) 1.94 (0.97-3.89) 0.060
Urinary catheter (%) 119 (93.0) 28 (59.6) 8.97 (3.67-21.93) < 0.001
Dialysis (%) 12 (9.4) 4 (8.5) 1.11 (0.34-3.64) 1.000
Drinking (%) 28 (21.9) 12 (25.5) 0.82 (0.38-1.78) 0.610
Smoking (%) 25 (19.5) 10 (21.3) 0.90 (0.39-2.05) 0.798
OR, odds ratio; CI, confidence interval; MRSA, methicillin resistant Staphylococcus aureus; SD, standard deviation; SSTI, skin and soft tissue infections.
Table 3. Summary of PFGE type along with SCCmec and MLST
PFGE type Imported (%) Acquired (%) Total (%) SCCmec spa  MLST
A 5 (6.9) 16 (8.6) 21 (8.1) II or II variant spa A* ST5
B 16 (22.2) 104 (55.9) 120 (46.5) II or II variant spa A* ST5
C 1 (1.4) 5 (2.7) 6 (2.3) II  spa A* ST5
D 36 (50.0) 22 (11.8) 58 (22.5) IVA spa B* ST72
E 2 (2.8) 22 (11.8) 24 (9.3) III t037 ST239
F 1 (1.4) 2 (1.1) 3 (1.2) IVA spa D* ST1
G 0 (0) 5 (2.7) 5 (1.9) II variant spa A* ST5
I 2 (2.8) 1 (0.5) 3 (1.2) III t037 ST239
J 3 (4.2) 2 (1.1) 5 (1.9) II variant t375 ST89
K 2 (2.8) 1 (0.5) 3 (1.2) II  spa A* ST5
M 0 (0) 3 (1.6) 3 (1.2) II  spa A* ST5
N 1 (1.4) 1 (0.5) 2 (0.8) NT NT ST254
O 3 (4.2) 2 (1.1) 5 (1.9) II or II variant spa A* ST5
Total 72 (100) 186 (100) 258 (100)
*Indicates that the spa complex was determined by visual analysis. The same complex shares the common short sequence repeats. PFGE, pulsed field gel electrophoresis; SCC, 
staphylococcal cassette chromosome; MLST, multilocus sequence typing; NT, not typed.Kwon J-C, et al.  •  Molecular Epidemiology of MRSA Isolates at Intensive Care Units
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Antibiotic susceptibility and PFGE types
Results of antibiotic susceptibility were not available in 2 of bac-
teremia and 5 of nasal colonization. Tetracycline (TC) suscepti-
bility was reported in only 225 out of 258 isolates. Of all MRSA 
isolates, each antibiotic susceptibility rate to ciprofloxacin (CPX), 
TC, clindamycin (CDM) and trimethoprim/sulfamethoxazole 
(TMP/SMX) was 24.3%, 32.9%, 21.9%, and 88.0%, respectively. 
Among MRSA isolates with PFGE type B, susceptibility rates 
were 0.8%, 4.8%, 0.8% and 93.2%, in contrast to the 96.5%, 96.0%, 
86.0% and 100% found among MRSA isolates with PFGE type D. 
We found that susceptibility to CPX (sensitivity 96.5%; specifici-
ty 96.9%; odds ratio 861; 95% confidence interval [CI] 169-4,390, 
P < 0.001) best predicted a community genotype, i.e., PFGE type 
D (SCCmec type IVA/ST72). The positive predictive value (PPV) 
for identifying a PFGE type D was 90.2% (Table 5). The PPV of 
CPX susceptibility was the highest when analyzing bacteremia 
and nasal colonization separately (85.7% and 92.5%, respec-
tively).
Nasal recolonization
Nasal recolonization of MRSA was identified in 23 cases. Among 
these cases, 7 (30.4%) MRSA strains were different from the orig-
inally colonized ones on the basis of PFGE types (Table 6). Mean 
duration of ICU stay was significantly longer in the recolonizers 
than non-recolonizers (37.6 days vs 21.9 days, P  =  0.031).
 
DISCUSSION
This study investigated the molecular epidemiology and the re-
lationship between antibiotic susceptibility pattern and PFGE 
types of MRSA strains isolated from ICU patients with bactere-
mia and nasal colonization.
  The PFGE patterns of MRSA were diverse in several studies. 
A few genotypes were dominant in some studies (20, 21), but 
not so in others (22, 23). Overall, 13 genotypes were identified 
with 2 major types. PFGE type B and D counted for 69.0% and 
in combination with type A and E, 4 PFGE types counted for 
more than 85%. Although the number of PFGE types in bacte-
remia and nasal colonization was 11 and 13, PFGE types B and 
D accounted for 78.3% and 64.6%, respectively and most types 
had less than 7 isolates (Table 4). PFGE type B in the acquired 
group and type D in the imported group comprised more than 
50% for each group (Table 4). PFGE type B was the second most 
Table 4. Comparison of PFGE pattern of MRSA between bacteremia and nasal carrier and between acquired and imported groups
PFGE 
pattern
No. (%) of isolates
OR (95% CI) P value
No. (%) of isolates
OR (95% CI) P value Total (%)
Bacteremia Nasal carrier Acquired Imported
A 1 (1.2) 20 (11.4) 0.10 (0.01-0.72) 0.003 16 (8.6) 5 (6.9) 1.26 (0.44-3.58) 0.662 21 (8.1)
B 45 (54.2) 75 (42.9) 1.58 (0.93-2.67) 0.087 104 (55.9) 16 (22.2) 4.44 (2.37-8.31) < 0.001 120 (46.5)
C 0 (0) 6 (3.4) 1.04 (1.01-1.07) 0.181 5 (2.7) 1 (1.4) 1.96 (0.23-17.08) 1.000 6 (2.3)
D 20 (24.1) 38 (21.7) 1.15 (0.62-2.12) 0.669 22 (11.8) 36 (50.0) 0.13 (0.07-0.26) < 0.001 58 (22.5)
E 6 (7.2) 18 (10.3) 0.68 (0.26-1.78) 0.499 22 (11.8) 2 (2.8) 4.70 (1.08-20.51) 0.029 24 (9.3)
F 2 (2.4) 1 (0.6) 4.30 (0.38-48.07) 0.243 2 (1.1) 1 (1.4) 0.77 (0.07-8.64) 1.000 3 (1.2)
G 1 (1.2) 4 (2.3) 0.52 (0.06-4.74) 1.000 5 (2.7) 0 (0) 0.97 (0.95-1.00) 0.326 5 (1.9)
I 2 (2.4) 1 (0.6) 4.30 (0.38-48.07) 0.243 1 (0.5) 2 (2.8) 0.19 (0.02-2.12) 0.189 3 (1.2)
J 3 (3.6) 2 (1.1) 3.24 (0.53-19.80) 0.332 2 (1.1) 3 (4.2) 0.25 (0.04-1.53) 0.134 5 (1.9)
K 1 (1.2) 2 (1.1) 1.06 (0.09-11.80) 1.000 1 (0.5) 2 (2.8) 0.19 (0.02-2.12) 0.189 3 (1.2)
M 1 (1.2) 2 (1.1) 1.06 (0.09-11.80) 1.000 3 (1.6) 0 (0) 0.98 (0.97-1.00) 0.562 3 (1.2)
N 0 (0) 2 (1.1) 1.01 (1.00-1.03) 1.000 1 (0.5) 1 (1.4) 0.38 (0.02-6.22) 0.481 2 (0.8)
O 1 (1.2) 4 (2.3) 0.52 (0.06-4.74) 1.000 2 (1.1) 3 (4.2) 0.25 (0.04-1.53) 0.134 5 (1.9)
SUM 83 175 186 72 258
PFGE, pulsed field gel electrophoresis; MRSA, methicillin resistant Staphylococcus aureus; OR, odds ratio; CI, confidence interval.
Table 5. A phenotypic rule for predicting a PFGE type D (SCCmec type IVA/ST72) based on antibiotic susceptibility
Antibiotics Susceptibility (%) Sensitivity (%) Specificity (%)     OR (95% CI) P value PPV (%)
CPX 24.3 96.5 96.9      861 (169-4,390) < 0.001 90.2
TC 32.9 96.0 85.1 137 (31-601) < 0.001 64.9
CDM 21.9 86.0 96.9 192 (64-579) < 0.001 89.1
PFGE, pulsed field gel electrophoresis; CPX, ciprofloxacin; TC, tetracycline; CDM, clindamycin; OR, odds ratio; CI, confidence interval; PPV, positive predictive value.
Table 6. PFGE patterns of initial and recolonized MRSA isolates
By same strain By different strain
PFGE pattern No. PFGE pattern No.
A→A 2 A→B 1
B→B 9 B→E 1
D→D 3 B→G 1
E→E 1 D→A 1
M→M 1 D→B 2
G→A 1
Subtotal (%) 16 (69.6%) Subtotal (%) 7 (30.4%)
PFGE pattern shows an arrow pointing from the first colonized strain to the recolonized 
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common PFGE type in the imported group, resulting in an in-
teresting contrast with the acquired group. Considering PFGE 
type B is SCCmec type II/ST5 genotype representing hospital 
genotype (HG) and type D is SCCmec type IVA/ST72 genotype 
representing community genotype (CG) epidemiologically in 
Korea (10, 12, 24), these findings suggest CG is dominant in the 
imported group. In addition, it is noticeable that CG (SCCmec 
type IVA/ST72) accounted for about 11.8% in the acquired group. 
Nosocomial MRSA infection by CG has increased recently and 
community-associated MRSA strains are emerging as major 
causes of bloodstream infections in healthcare settings in Korea 
(10). These findings are consistent with our results. Considering 
CG was prevalent in patients with history of hospitalization or 
long term care facility admission, there is a concern that classi-
fication between CG and HG genotype could prove to be am-
biguous in the future. In fact, among 258 isolates of bacteremia 
or nasal colonization, all but 8 cases had at least one healthcare-
associated risk factors.
  Lee et al. investigated the antimicrobial susceptibilities of 90 
MRSA clinical isolates at a tertiary hospital in Korea (25). The re-
sistance rate to CPX, TC, and CDM was 96.7%, 96.7%, and 86.7%, 
respectively. Various clinical specimens (e.g. pus, sputum, blood, 
sputum, etc.) were included in this study and the resistance rate 
to TMP/SMX was not reported. In another study in Korea, 36 
MRSA isolates were obtained from blood consecutively for 5 
months at a tertiary hospital, and the antibiotic resistance rate 
to CPX, TC, CDM and TMP/SMX was 83.3%, 72.2%, 83.3%, and 
8.3%, respectively (26). Similarly in our study, the antibiotic re-
sistance rate to CPX, TC, CDM and TMP/SMX in the bactere-
mia group was 72.8%, 70.4%, 80.2%, and 7.4%, respectively.
  Popovich et al. (8) assessed the performance characteristics 
of a rule using the antimicrobial phenotype to predict genotype 
from 147 MRSA bloodstream isolates in a tertiary hospital. USA-
300 and USA-400 were classified as CG; USA-100, USA-500, and 
USA-800 were labeled HG. A CG was seen in 86 isolates. Suscep-
tibility to CDM (sensitivity, 95%; specificity, 80%; likelihood ratio, 
4.86; 95% CI, 3.29 to 6.47) or fluoroquinolones (sensitivity, 73%; 
specificity, 86%; likelihood ratio, 5.34; 95% CI, 2.91 to 10.58) best 
predicted a CG (8). We applied this rule to both bacteremia and 
nasal carrier isolates. Of all isolates, susceptibility to CPX was 
best for predicting a CG (SCCmec type IVA/ST72) (sensitivity, 
96.5%; specificity, 96.9%; odds ratio, 861; 95% CI, 169-4390, P < 
0.001) and the PPV was 90.2%. In a separate analysis for each 
group, CPX susceptibility was the best predictive rule. This means 
that certain phenotype can be used to predict specific genotype, 
and it is useful when genotype test is not available or while wait-
ing for genotypic results. However, because the epidemiology 
of phenotype and genotype are not constantly maintained in a 
certain geographic region or hospital, periodic re-evaluation 
and accumulation of data are essential to apply temporally ap-
propriate phenotypic rule (10, 23, 27). Huang et al. (23) studied 
changing molecular epidemiology of MRSA bloodstream iso-
lates collected from a teaching hospital over a 4-yr interval. PFGE 
type A accounted for 78.2% (97/124) during 2000 to 2001, but 
decreased to 30.6% (38/124) during 2004 to 2005. However, PFGE 
type B, D, F, and AH increased from less than 3% (0.0%-2.4%)  
to more than 10% (10.5%-12.1%), while type D did not change 
during the same period. In Korea, Park et al. (10) reported CG 
(SCCmec type IVA) MRSA bloodstream infections increased 
more than the past among patients with healthcare-associated 
risk factors.
  Corbella et al. (28) studied the relationship between S. aureus 
nasal carriage and subsequent staphylococcal infection. They 
reported one nasal carrier initially colonized by methicillin sus-
ceptible S. aureus (MSSA) was recolonized by MRSA. In our 
study, 23 cases were recolonized by MRSA in subsequent sur-
veillance nasal cultures after successful eradication. Among 
them, 7 (30.4%) MRSA strains were different from the originally 
colonized strains on the basis of PFGE types. The longer dura-
tion of ICU stay in the recolonizers (37.6 days vs 21.9 days, P = 
0.031) may contribute to reacquiring nasal MRSA. Healthcare 
workers such as doctors or nurses, visitors and other patients 
could be potential sources of subsequent repetitive MRSA car-
riage. Cross-contamination through transient colonization of 
the hands of healthcare personnel is a common route of patient-
to-patient transmission of MRSA (29). However, further research 
will be needed to identify their origin.
  This study has several limitations. Although MRSA isolates 
were collected prospectively, some of them were missed. Also, 
cases of nasal carriage of MRSA were collected from only 3 hos-
pitals compared with those of bacteremia, which were collected 
from 10 hospitals. But all collected strains were carried to the 
central laboratory for molecular analysis. Second, because this 
study was not designed to investigate the direct relationship be-
tween nasal carrier and subsequent bacteremia, no temporal 
and spatial interpretation between these 2 groups could be in-
ferred. Third, although the antibiotic predictive rule can help to 
make an estimation of molecular epidemiology, objective data 
on which the predictive rule is based may change with time, re-
sulting in limited clinical decision making applicability.
  In conclusion, PFGE patterns of MRSA at tertiary hospital 
ICUs in Korea are diverse, but a small number of clones form 
more than 85%. Community strains and hospital strains have 
been already mixed up in Korean ICUs. CPX susceptibility could 
be a useful tool for predicting SCCmec type IVA/ST72, the CG in 
Korea. About one third of nasal MRSA recolonizations in ICUs 
are new strains on the basis of PFGE types.
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Staphylococcus aureus is a major cause of serious infections in both hospitals and the community. Increasing rates of methicillin-
resistant Staphylococcus aureus (MRSA) infection is now a worldwide health problem. We investigated molecular epidemiology of 
MRSA isolates from blood and nasal secretion at 10 University-affiliated hospital ICUs (from October 2008 to May 2009). Pulsed-
field gel electrophoresis (PFGE) patterns were diverse; PFGE type B was dominant in the ICU-acquired group and PFGE type D in 
the ICU-imported group. PFGE type D, which represents community genotype epidemiologically in Korea, accounted for more 
than 10% in the ICU-acquired group. This suggests that community strains and hospital strains have been already mixed up in 
Korean ICUs. Among MRSA isolates with PFGE type D, susceptibility rate to ciprofloxacin was 96.5%. The susceptibility to 
ciprofloxacin best predicted a community genotype, i.e., PFGE type D.